Salem Investment Counselors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $94.7M | Buy |
78,924
+371
| +0.5% | +$379K | 2.35% | 10 |
|
|
2026
Q1 | $72.3M | Sell |
78,553
-702
| -0.9% | -$712K | 2.12% | 11 |
|
|
2025
Q4 | $85.2M | Sell |
79,255
-909
| -1% | -$869K | 2.41% | 10 |
|
|
2025
Q3 | $61.2M | Buy |
80,164
+8,295
| +12% | +$6.17M | 1.75% | 12 |
|
|
2025
Q2 | $56M | Buy |
71,869
+426
| +0.6% | +$331K | 1.78% | 11 |
|
|
2025
Q1 | $59M | Buy |
71,443
+2,827
| +4% | +$2.35M | 2.05% | 10 |
|
|
2024
Q4 | $53M | Sell |
68,616
-2,265
| -3% | -$1.88M | 1.74% | 11 |
|
|
2024
Q3 | $62.8M | Sell |
70,881
-669
| -0.9% | -$601K | 1.89% | 10 |
|
|
2024
Q2 | $64.8M | Sell |
71,550
-788
| -1% | -$630K | 2.09% | 9 |
|
|
2024
Q1 | $56.3M | Buy |
72,338
+1,961
| +3% | +$1.4M | 1.85% | 9 |
|
|
2023
Q4 | $41M | Buy |
70,377
+5,991
| +9% | +$3.5M | 1.41% | 10 |
|
|
2023
Q3 | $34.6M | Buy |
64,386
+7,219
| +13% | +$3.72M | 1.32% | 11 |
|
|
2023
Q2 | $26.8M | Sell |
57,167
-35
| -0.1% | -$14.7K | 0.97% | 17 |
|
|
2023
Q1 | $19.6M | Sell |
57,202
-950
| -2% | -$320K | 0.79% | 22 |
|
|
2022
Q4 | $21.3M | Buy |
58,152
+1,650
| +3% | +$585K | 0.91% | 19 |
|
|
2022
Q3 | $18.3M | Buy |
56,502
+3,818
| +7% | +$1.21M | 0.83% | 20 |
|
|
2022
Q2 | $17.1M | Buy |
52,684
+3,008
| +6% | +$903K | 0.78% | 26 |
|
|
2022
Q1 | $14.2M | Buy |
49,676
+1,049
| +2% | +$270K | 0.56% | 31 |
|
|
2021
Q4 | $13.4M | Buy |
48,627
+246
| +0.5% | +$62.4K | 0.47% | 38 |
|
|
2021
Q3 | $11.2M | Buy |
48,381
+3,280
| +7% | +$810K | 0.61% | 42 |
|
|
2021
Q2 | $10.4M | Sell |
45,101
-820
| -2% | -$165K | 0.57% | 45 |
|
|
2021
Q1 | $8.58M | Buy |
45,921
+4,983
| +12% | +$975K | 0.52% | 52 |
|
|
2020
Q4 | $6.91M | Buy |
40,938
+3,484
| +9% | +$520K | 0.46% | 56 |
|
|
2020
Q3 | $5.54M | Sell |
37,454
-854
| -2% | -$132K | 0.42% | 55 |
|
|
2020
Q2 | $6.29M | Buy |
38,308
+2,770
| +8% | +$425K | 0.53% | 48 |
|
|
2020
Q1 | $4.93M | Sell |
35,538
-705
| -2% | -$96.9K | 0.51% | 51 |
|
|
2019
Q4 | $4.76M | Buy |
36,243
+280
| +0.8% | +$32.5K | 0.39% | 61 |
|
|
2019
Q3 | $4.02M | Sell |
35,963
-100
| -0.3% | -$11.1K | 0.37% | 64 |
|
|
2019
Q2 | $4M | Buy |
36,063
+3,368
| +10% | +$397K | 0.37% | 71 |
|
|
2019
Q1 | $3.51M | Sell |
32,695
-453
| -1% | -$55.1K | 0.36% | 67 |
|
|
2018
Q4 | $3.84M | Buy |
33,148
+453
| +1% | +$50.6K | 0.48% | 49 |
|
|
2018
Q3 | $3.51M | Sell |
32,695
-199
| -0.6% | -$19.9K | 0.36% | 67 |
|
|
2018
Q2 | $2.75M | Sell |
32,894
-2,415
| -7% | -$198K | 0.25% | 73 |
|
|
2018
Q1 | $2.71M | Sell |
35,309
-19,295
| -35% | -$1.55M | 0.31% | 73 |
|
|
2017
Q4 | $4.61M | Buy |
54,604
+6,144
| +13% | +$523K | 0.5% | 53 |
|
|
2017
Q3 | $4.17M | Buy |
48,460
+3,400
| +8% | +$279K | 0.49% | 54 |
|
|
2017
Q2 | $3.71M | Buy |
45,060
+9,260
| +26% | +$755K | 0.43% | 53 |
|
|
2017
Q1 | $3.02M | Buy |
35,800
+6,754
| +23% | +$541K | 0.32% | 75 |
|
|
2016
Q4 | $2.14M | Buy |
+29,046
| New | +$2.16M | 0.24% | 86 |
|
|
2016
Q3 | – | Sell |
-4,895
| Closed | -$385K | – | 535 |
|
|
2016
Q2 | $385K | Sell |
4,895
-799
| -14% | -$60.2K | 0.05% | 197 |
|
|
2016
Q1 | $410K | Buy |
5,694
+805
| +16% | +$60.9K | 0.05% | 183 |
|
|
2015
Q4 | $412K | Hold |
4,889
| – | – | 0.05% | 183 |
|
|
2015
Q3 | $405K | Buy |
4,889
+1
| +0% | +$84 | 0.05% | 187 |
|
|
2015
Q2 | $408K | Sell |
4,888
-582
| -11% | -$44.3K | 0.05% | 201 |
|
|
2015
Q1 | $397K | Buy |
5,470
+1,600
| +41% | +$114K | 0.05% | 211 |
|
|
2014
Q4 | $267K | Sell |
3,870
-50
| -1% | -$3.38K | 0.03% | 233 |
|
|
2014
Q3 | $254K | Hold |
3,920
| – | – | 0.03% | 248 |
|
|
2014
Q2 | $244K | Sell |
3,920
-204
| -5% | -$12.2K | 0.03% | 255 |
|
|
2014
Q1 | $243K | Sell |
4,124
-300
| -7% | -$16.7K | 0.03% | 259 |
|
|
2013
Q4 | $226K | Buy |
4,424
+50
| +1% | +$2.5K | 0.03% | 248 |
|
|
2013
Q3 | $220K | Hold |
4,374
| – | – | 0.03% | 252 |
|
|
2013
Q2 | $215K | Buy |
+4,374
| New | +$238K | 0.03% | 246 |
|
Other funds holding LLY
SC
ONB
GIM
Salem Investment Counselors's LLY Position: Q2 2026 in Review
Salem Investment Counselors increased its Eli Lilly (LLY) stake by 0.47% in Q2 2026, buying an estimated $379K and bringing the position to 78,924 shares worth $94.7M. The position accounts for 2.35% of the portfolio, ranked #10.
Salem Investment Counselors first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 1,718 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Salem Investment Counselors held 78,924 shares of Eli Lilly worth $94.7M as of Q2 2026.
- Salem Investment Counselors bought 371 Eli Lilly shares in Q2 2026, an estimated $379K.
- Eli Lilly made up 2.35% of Salem Investment Counselors's portfolio in Q2 2026, its #10 holding.
- Salem Investment Counselors first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- 1,718 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Salem Investment Counselors's 13F filing for Q2 2026, filed 14 Jul 2026.